Sperm selection by birefringence: a promising non-invasive tool to improve ICSI outcomes.


Journal

JBRA assisted reproduction
ISSN: 1518-0557
Titre abrégé: JBRA Assist Reprod
Pays: Brazil
ID NLM: 101684552

Informations de publication

Date de publication:
22 Jun 2023
Historique:
medline: 26 6 2023
pubmed: 6 12 2022
entrez: 5 12 2022
Statut: epublish

Résumé

Despite higher sperm DNA fragmentation may affect intracytoplasmic sperm injection (ICSI) outcomes, sperm selection protocols do not evaluate this parameter. Therefore, sperm's head birefringence has been suggested as an adjuvant of seminal processing to select viable sperm for couples with severe male factor. Considering men with normal seminal parameters may also curse with DNA fragmentation, the aim of this study was to evaluate the impact of sperm selection by birefringence on ICSI outcomes in couples with different infertility factors compared to those submitted to conventional sperm selection. In this case-control study, medical records from 181 couples who underwent ICSI from January 2018 to August 2020 (107 from the Conventional and 74 from the Birefringence group) were included in the study. Clinical characteristics and ICSI outcomes were compared between the groups using Student's t test or Chi-square test (p<0.05) and a multivariate logistic regression model was applied regarding clinical pregnancy. Despite the Birefringence group showed higher female age (p=0.01), lower seminal sperm concentration (p<0.01) and higher sperm DNA fragmentation (p<0.01), those patients cursed with both higher cleavage rate (p=0.04), clinical pregnancy rate per transfer (p=0.03) and clinical pregnancy rate per initiated cycle (p=0.02). The logistic regression showed a positive group effect on clinical pregnancy. The findings suggest a positive clinical impact of this cheap and easily reproducible adjuvant technique on ICSI outcomes in couples with different infertility factors. If confirmed by further methodologically appropriate studies, the sperm's head birefringence could be considered to improve the reproductive chances of those patients.

Identifiants

pubmed: 36468799
doi: 10.5935/1518-0557.20220055
pmc: PMC10279423
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-240

Auteurs

Mariana Antunes Ribeiro (MA)

Human Reproduction Institute - Fivmed, Campinas, São Paulo, CEP 13073-002, Brazil.

Michele Gomes Da Broi (MGD)

Human Reproduction Institute - Fivmed, Campinas, São Paulo, CEP 13073-002, Brazil.

Mauro Bibancos de Rose (MB)

Human Reproduction Institute - Fivmed, Campinas, São Paulo, CEP 13073-002, Brazil.

Andrea Garolla (A)

Section of Clinical Pathology and Unit for Human Reproduction Pathology, Department of Medicine, University of Padova, Padova, Italy.

Carlo Foresta (C)

Section of Clinical Pathology and Unit for Human Reproduction Pathology, Department of Medicine, University of Padova, Padova, Italy.

Aristides Manoel Dos Santos Bragheto (AMDS)

Human Reproduction Institute - Fivmed, Campinas, São Paulo, CEP 13073-002, Brazil.

Daniel Gustavo Faúndes Hardy (DGF)

Human Reproduction Institute - Fivmed, Campinas, São Paulo, CEP 13073-002, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH